Researchers Warn Against the Increasing Use of ‘Just in Case’ Antibiotics
Researchers from the University of California, San Francisco, warn against the increasing use of “just in case” antibiotics, citing a rise in antibiotic resistance as a critical public health issue. According to a 2023 report by the World Health Organization (WHO), antibiotic resistance has become a global threat, with an estimated 1.27 million deaths linked to drug-resistant infections in 2019.
What Is ‘Just in Case’ Antibiotic Use?
“just in case” antibiotic use refers to the prescription or consumption of antibiotics without a confirmed bacterial infection. This practice, often driven by patient demand or physician caution, involves administering antibiotics prophylactically—before symptoms appear or without diagnostic confirmation. A 2022 study in *The Lancet Infectious Diseases* found that 30% of antibiotic prescriptions in outpatient settings lack a clear bacterial indication, contributing to resistance.
Why Is This a Public Health Concern?
Antibiotic resistance occurs when bacteria evolve to survive exposure to drugs designed to kill them. The Centers for Disease Control and Prevention (CDC) estimates that at least 2.8 million antibiotic-resistant infections occur in the U.S. annually, leading to more than 35,000 deaths. “Every unnecessary antibiotic use accelerates the development of resistant strains,” said Dr. Sarah Lin, an infectious disease specialist at the CDC. “This undermines our ability to treat common infections like pneumonia or urinary tract infections.”
What Are the Risks of Overuse?
Overuse of antibiotics disrupts the body’s microbiome, increasing the risk of opportunistic infections such as *Clostridioides difficile* (C. diff). A 2021 study in *JAMA Internal Medicine* linked frequent antibiotic use to a 40% higher risk of recurrent C. diff infections. Additionally, resistant bacteria can spread between individuals, as seen in the 2022 outbreak of carbapenem-resistant *Enterobacterales* (CRE) in a U.S. hospital, which was traced to prior antibiotic misuse.
How Can Patients and Providers Address This?
The WHO recommends that healthcare providers adhere to evidence-based guidelines, such as the CDC’s “Choosing Wisely” campaign, which advises against antibiotics for viral infections like the common cold. Patients should ask questions about the necessity of prescriptions and avoid requesting antibiotics for non-bacterial conditions. “Education is key,” said Dr. Lin. “Patients need to understand that antibiotics are not a cure-all and that resistance is a real, growing threat.”
What Are the Global Implications?
Antibiotic resistance is a transnational issue. A 2023 analysis by the Lancet Commission found that low- and middle-income countries face disproportionate risks due to limited access to diagnostic tools and regulatory oversight. In contrast, high-income nations like the U.S. and Germany have seen declines in inappropriate prescribing through stricter guidelines. However, the WHO warns that without global coordination, resistance could reverse decades of progress in infectious disease control.
What’s Next for Antibiotic Stewardship?
Public health officials are pushing for expanded antibiotic stewardship programs, which monitor and optimize antibiotic use. The CDC’s 2024 National Action Plan emphasizes improving diagnostics, enhancing surveillance, and promoting public awareness. “We must treat antibiotics as a finite resource,” said Dr. Lin. “Their overuse today could leave us powerless to fight infections tomorrow.”
World Health Organization: Antimicrobial Resistance
Centers for Disease Control and Prevention: Antibiotic Resistance
The Lancet Infectious Diseases: Antibiotic Use in Outpatient Settings